• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why IZEA Worldwide Shares Are Trading Higher By Over 30%: Here Are 37 Stocks Moving Premarket

    8/16/22 6:25:23 AM ET
    $AIHS
    $AIM
    $ASTS
    $CIDM
    Finance: Consumer Services
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AIHS alert in real time by email

    Gainers

    • IZEA Worldwide, Inc. (NASDAQ:IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million, beating the consensus of $9.75 million.
    • GreenBox POS (NASDAQ:GBOX) shares rose 29.9% to $1.65 in pre-market trading as the company reported better-than-expected Q2 sales.
    • TransGlobe Energy Corporation (NASDAQ:TGA) rose 20% to $3.96 in pre-market trading after declining 4% on Monday.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shares rose 17.5% to $4.10 in pre-market trading after the company said Q2 sales results were up year over year and raised FY22 sales guidance above estimates.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) rose 16.3% to $10.80 in pre-market trading. Mainz Biomed and Dante Genomics announced full commercial availability of ColoAlert in Italy and the United Arab Emirates.
    • Energy Services of America Corporation (NASDAQ:ESOA) rose 15.6% to $2.75 in pre-market trading. Energy Services Of America posted Q2 earnings of $0.10 per share on sales of $51.17 million.
    • Forza X1, Inc. (NASDAQ:FRZA) rose 13.4% to $6.87 in pre-market trading after declining 19% on Monday.
    • AIM ImmunoTech Inc. (NYSE:AIM) rose 13.1% to $0.8880 in pre-market trading. The company issued an update on Jorgl activist group litigation. AIM ImmunoTech, on Monday, posted a Q2 loss of $0.10 per share.
    • GigaMedia Limited (NASDAQ:GIGM) rose 12.9% to $2.62 in pre-market trading after jumping over 41% on Monday. GigaMedia, last month, posted a Q2 loss of $0.10 per share.
    • Treasure Global Inc. (NASDAQ:TGL) shares rose 12.8% to $8.12 in pre-market trading after the company reported closing of upsized $9.2 million initial public offering, Nasdaq listing, and full exercise of underwriter’s over-allotment option.
    • Embark Technology, Inc. (NASDAQ:EMBK) rose 12.6% to $0.8259 in pre-market trading after dropping around 32% on Monday. Embark Technology, last week, reported better-than-expected Q2 EPS results.
    • OKYO Pharma Limited (NASDAQ:OKYO) rose 11.8% to $2.37 in pre-market trading after reporting its final audited results for the year ended 31 March 2022.
    • Nu Holdings Ltd. (NYSE:NU) rose 11.3% to $5.21 in pre-market trading following strong quarterly sales.
    • Magic Empire Global Limited (NASDAQ:MEGL) shares rose 10.1% to $19.52 in pre-market trading. Magic Empire shares jumped over 115% on Monday on volatility following the company's IPO earlier this month.
    • Uxin Limited (NASDAQ:UXIN) rose 9.4% to $0.6776 in pre-market trading. The company, last month, posted a profit for the fourth quarter.
    • Unity Biotechnology, Inc.(NASDAQ:UBX) rose 9.2% to $1.41 in pre-market trading. UNITY Biotechnology recently disclosed positive 12 and 18-week data from its Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema (DME).
    • Senmiao Technology Limited (NASDAQ:AIHS) rose 8.9% to $1.10 in pre-market trading after the company posted a profit for the first quarter.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) rose 8.1% to $3.49 in pre-market trading after declining around 4% on Monday.
    • IonQ, Inc. (NYSE:IONQ) rose 6.5% to $6.77 in pre-market trading following upbeat Q2 sales.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Save Foods, Inc. (NASDAQ:SVFD) shares fell 31.9% to $3.24 in pre-market trading after the company reported the pricing of a public offering of 1,600,000 shares at $3.00 per share.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares fell 20.7% to $0.1628 in pre-market trading after the company reported a wider Q2 loss and announced worse-than-expected sales results.
    • Hallmark Financial Services, Inc. (NASDAQ:HALL) fell 17.7% to $2.05 in pre-market trading after the company posted a wider quarterly loss.
    • iSun, Inc. (NASDAQ:ISUN) fell 17.7% to $4.02 in pre-market trading as the company posted a wider loss for its second quarter.
    • Polished.com Inc. (NYSE:POL) fell 14.6% to $1.29 in pre-market trading. Polished.com said it sees preliminary Q2 sales of $145 million to $150 million, versus analysts’ estimates of $156.15 million.
    • Tremor International Ltd (NASDAQ:TRMR) fell 14.1% to $8.94 in pre-market trading after declining around 5% on Monday.
    • GAN Limited (NASDAQ:GAN) fell 13.6% to $3.75 in pre-market trading after the company reported worse-than-expected Q2 sales results and issued FY22 sales guidance below estimates.
    • MiNK Therapeutics, Inc. (NASDAQ:INKT) fell 12.1% to $2.99 in pre-market trading after gaining 99% on Monday.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 10.8% to $0.24 in pre-market trading.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) fell 10% to $11.48 in pre-market trading after reporting Q2 results.
    • Vislink Technologies, Inc. (NASDAQ:VISL) fell 9.5% to $0.62 in pre-market trading after reporting a wider quarterly loss.
    • Remark Holdings, Inc. (NASDAQ:MARK) shares fell 9.3% to $0.49 in pre-market trading after posting downbeat quarterly sales.
    • Helbiz, Inc. (NASDAQ:HLBZ) fell 9.1% to $1.30 in pre-market trading. Helbiz posted a Q2 loss of $0.57 per share.
    • Trinity Capital Inc. (NASDAQ:TRIN) fell 8.6% to $14.88 in pre-market trading after the company reported pricing of $55.0 million of shares in upsized offering of common stock.
    • Arcimoto, Inc. (NASDAQ:FUV) fell 7.9% to $2.81 in pre-market trading following weak Q2 results. Arcimoto also said due to uncertainty caused by supply chain headwinds co. will not meet prior FY production guidance.
    • Cinedigm Corp. (NASDAQ:CIDM) fell 7.4% to $0.7068 in pre-market trading after posting a loss for the first quarter.
    • Sema4 Holdings Corp. (NASDAQ:SMFR) fell 6.3% to $2.25 in pre-market trading after the company reported a drop in Q2 sales and issued weak FY22 sales forecast.
    • GoHealth, Inc. (NASDAQ:GOCO) shares fell 6.2% to $0.8290 in pre-market trading following downbeat quarterly earnings.
    Get the next $AIHS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIHS
    $AIM
    $ASTS
    $CIDM

    CompanyDatePrice TargetRatingAnalyst
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    AST SpaceMobile Inc.
    $ASTS
    1/13/2026$105.00Buy → Neutral
    B. Riley Securities
    AST SpaceMobile Inc.
    $ASTS
    1/7/2026$45.60Sector Perform → Sector Underperform
    Scotiabank
    IonQ Inc.
    $IONQ
    12/17/2025$60.00Outperform
    Wedbush
    IonQ Inc.
    $IONQ
    12/16/2025$100.00Buy
    Jefferies
    IonQ Inc.
    $IONQ
    12/11/2025$90.00Outperform
    Mizuho
    Trinity Capital Inc.
    $TRIN
    12/8/2025$17.50Mkt Outperform
    Citizens JMP
    OKYO Pharma Limited
    $OKYO
    12/8/2025$5.00Buy
    B. Riley Securities
    More analyst ratings

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on OKYO Pharma with a new price target

    Piper Sandler initiated coverage of OKYO Pharma with a rating of Overweight and set a new price target of $7.00

    2/20/26 8:25:04 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    AST SpaceMobile downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded AST SpaceMobile from Buy to Neutral and set a new price target of $105.00

    1/13/26 9:00:28 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    AST SpaceMobile downgraded by Scotiabank with a new price target

    Scotiabank downgraded AST SpaceMobile from Sector Perform to Sector Underperform and set a new price target of $45.60

    1/7/26 8:53:24 AM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $AIHS
    $AIM
    $ASTS
    $CIDM
    SEC Filings

    View All

    AIM ImmunoTech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - AIM ImmunoTech Inc. (0000946644) (Filer)

    3/6/26 5:15:32 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 424B7 filed by IonQ Inc.

    424B7 - IonQ, Inc. (0001824920) (Filer)

    3/5/26 5:00:20 PM ET
    $IONQ
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13D/A filed by AST SpaceMobile Inc.

    SCHEDULE 13D/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    3/3/26 6:24:11 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair, IonQ Federal Cardillo Robert T. was granted 31,651 shares, increasing direct ownership by 29% to 140,871 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    3/4/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    CEO, President and CIO Brown Kyle Steven bought $49,662 worth of shares (3,333 units at $14.90), increasing direct ownership by 0.89% to 376,775 units (SEC Form 4)

    4 - Trinity Capital Inc. (0001786108) (Issuer)

    3/4/26 9:00:04 PM ET
    $TRIN
    Finance: Consumer Services
    Finance

    Director Estes Ronald E. bought $2,946 worth of shares (200 units at $14.73), increasing direct ownership by 0.51% to 39,038 units (SEC Form 4)

    4 - Trinity Capital Inc. (0001786108) (Issuer)

    3/4/26 9:00:03 PM ET
    $TRIN
    Finance: Consumer Services
    Finance

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, President and CIO Brown Kyle Steven bought $49,662 worth of shares (3,333 units at $14.90), increasing direct ownership by 0.89% to 376,775 units (SEC Form 4)

    4 - Trinity Capital Inc. (0001786108) (Issuer)

    3/4/26 9:00:04 PM ET
    $TRIN
    Finance: Consumer Services
    Finance

    Director Estes Ronald E. bought $2,946 worth of shares (200 units at $14.73), increasing direct ownership by 0.51% to 39,038 units (SEC Form 4)

    4 - Trinity Capital Inc. (0001786108) (Issuer)

    3/4/26 9:00:03 PM ET
    $TRIN
    Finance: Consumer Services
    Finance

    Director Teuber William J Jr bought $115,155 worth of shares (3,000 units at $38.38), increasing direct ownership by 47% to 9,413 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AIM ImmunoTech Announces Closing of its Rights Offering

    OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) – AIM ImmunoTech Inc. ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic cancer – a lethal and unmet global health problem – announced today the closing of its previously announced rights offering (the "Rights Offering"). The Rights Offering resulted in total subscriptions of approximately $1.8 million. Each right entitled the holder to purchase one unit ("Unit"), at a subscription price of $1,000 per Unit, consisting of one share of the Company's Series G Convertible Preferred Stock

    3/6/26 7:00:00 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Quantum Threats Are Real. These Companies Are Building the Fix

    Issued on behalf of Quantum Secure Encryption Corp. (QSE)USA News Group News CommentaryVANCOUVER, BC, March 6, 2026 /CNW/ -- A quantum-enabled cyberattack on a single major U.S. bank could trigger between $2.0 trillion and $3.3 trillion in cascading economic damage, according to a recent report from the Citi Institute[1]. That vulnerability is accelerating a global security overhaul, with global information security spending projected to reach $244.2 billion in 2026 as post-quantum cryptography emerges among the top forces reshaping enterprise defense[2]. Companies at the forefront of this transition include QSE Corp. (CSE:QSE) (OTCQB:QSEGF) (FSE: VN8), Arqit Quantum (NASDAQ:ARQQ), IonQ (NYS

    3/6/26 11:00:00 AM ET
    $ARQQ
    $IONQ
    $QBTS
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    Bloomberg 500 (B500) Index Adds Eleven Securities Following March Reconstitution

    NEW YORK, March 5, 2026 /PRNewswire/ -- Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index effective prior to the open of trading on Thursday, March 12, 2026, to coincide with the March reconstitution of the index. The B500 contains the 500 most highly capitalized US companies weighted by float market cap, reflecting a market capitalization of $58.19 trillion. AST SpaceMobile, Inc. (ASTS UW), Bloom Energy Corporation (BE UN), Ciena Corporation (CIEN UN), Coherent Corp.S (COHR UN), EchoStar Corporation (SATS UW), Flutter Entertainment PLC (FLUT UN

    3/5/26 8:30:00 AM ET
    $ALGN
    $ARE
    $ASTS
    Industrial Specialties
    Health Care
    Real Estate Investment Trusts
    Real Estate

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Leadership Updates

    Live Leadership Updates

    View All

    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

    Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli will lead the clinical and regulatory strategy to advance the company's development program in neuropathic corneal pain (NCP), leveraging urcosimod's FDA Fast Track designationThis appointment, following the recent CEO appointment, further strengthens OKYO's world-class ophthalmology leadership team LONDON and NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neur

    2/10/26 8:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Ying-Chih Liao Appointed Non-Independent Non-Executive Director of GigaMedia

    TAIPEI, Jan. 30, 2026 /PRNewswire/ -- GigaMedia Limited (NASDAQ:GIGM) today announced that its Board of Directors has appointed Mr. Ying-Chih Liao (a.k.a. Kevin Liao) as new non-independent non-executive director, effective on January 30, 2026. Mr. Ying-Chih Liao obtained a Bachelor of Laws degree in National Taiwan University and a Master of Laws degree in Law School of Harvard University. Mr. Liao had been a practicing attorney in a renowned law firm for many years, specialized in international corporate finance, commercial corporate, and mergers and acquisitions. He joined Chailease Holding Co., Ltd. as corporate management in 2006, and currently serves as senior executive vice president

    1/30/26 9:00:00 AM ET
    $GIGM
    Computer Software: Programming Data Processing
    Technology

    OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer

    Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on the Board LONDON and NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announces that, effective immediately, Robert J. Dempsey will assume the role of Chief Executive Officer. Gary S. Jacob, Ph.D. will transition to Chief Development Officer and

    1/5/26 7:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by AST SpaceMobile Inc.

    SC 13D/A - AST SpaceMobile, Inc. (0001780312) (Subject)

    11/20/24 9:59:14 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Unity Biotechnology Inc.

    SC 13G/A - Unity Biotechnology, Inc. (0001463361) (Subject)

    11/14/24 4:35:22 PM ET
    $UBX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIHS
    $AIM
    $ASTS
    $CIDM
    Financials

    Live finance-specific insights

    View All

    AST SpaceMobile Provides Business Update and Fourth Quarter and Full Year 2025 Results

    Reported revenue of $70.9 million for the full year 2025, driven by mobile network operator partners and the U.S. Government Secured over $1.2 billion in aggregate contracted revenue commitments from partners Successfully completed unfolding of BlueBird 6, the largest commercial communications array ever deployed in low Earth orbit, expected to greatly exceed 120 Mbps peak data speeds Continued orbital launch campaign with encapsulation of BlueBird 7 at Cape Canaveral in February and expected launch during March, with additional launches expected every one to two months on average to reach goal of 45 to 60 satellites in orbit by end of 2026 AST SpaceMobile, Inc. ("AST SpaceMobile")

    3/2/26 4:32:00 PM ET
    $ASTS
    Telecommunications Equipment
    Consumer Discretionary

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Trinity Capital Inc. Provides $50 Million in Growth Capital to Dwelly, Scaling UK Property-Management Marketplace

    PHOENIX, Feb. 26, 2026 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $50 million USD in growth capital to Dwelly, an AI-first lettings and property management platform. Dwelly is a London-based property technology company that acquires and integrates independent lettings agencies into its AI-powered property management platform, creating a unified ecosystem that streamlines operations and drives growth. Its platform automates key functions such as tenant onboarding, rent collection, main

    2/26/26 8:00:00 AM ET
    $TRIN
    Finance: Consumer Services
    Finance